We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ear Acupuncture for Acute Sore Throat.

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01302769
First Posted: February 24, 2011
Last Update Posted: February 3, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Mike O'Callaghan Federal Hospital
  Purpose
The purpose of this study is to compare ear acupuncture plus standard of care versus standard therapy (anti-inflammatory medications) in the reduction of pain, reduction in oral anti inflammatory medication use, hours lost from work in acute sore throat.

Condition Intervention
Acute Sore Throat Device: Standard treatment plus ear acupuncture

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Ear Acupuncture for Acute Sore Throat. A Randomized Controlled Trial.

Resource links provided by NLM:


Further study details as provided by Mike O'Callaghan Federal Hospital:

Primary Outcome Measures:
  • Reduction in Pain [ Time Frame: 5 months ]
    Subjects will be randomized to receive either standard treatment alone or standard treatment plus ear acupuncture. Subjects will be asked 15 minutes after their treatment to assess their pain on a scale of 0-10. After the subject has left the clinic, phone calls will be made at 6 hours, 24 hours and 48 hours to assess their pain level, ask about their missed hours from work, and ask the number of doses of ibuprofen taken. Subjects who report back after 48 hours with unimproved sore throat will be instructed to make a same day follow up with the clinic.


Enrollment: 65
Study Start Date: October 2011
Study Completion Date: August 2014
Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: battlefield auricular acupuncture
battlefield auricular acupuncture
Device: Standard treatment plus ear acupuncture
Standard treatment plus ear acupuncture
Other Name: Sedatelec ASP Original Gold needles
No Intervention: placebo

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion:

  • Male and female subjects (DoD beneficiaries), 18 years or older, with upper respiratory complaints and their primary symptom being acute sore throat.
  • Minimum pain score of 5 points on an 11 point scale (0-10 with 10 being the worst pain)

Exclusion:

  • History of significant gastrointestinal bleed
  • Previous documented history of stage 2 kidney disease or worse
  • Known Pregnancy
  • History of gastric bypass surgery
  • Known Peritonsillar abscess (PTA)
  • Throat, mouth or esophageal cancer
  • Chronic oral steroids use
  • Absence of one or more ears
  • Active cellulitis of ear
  • Ear anatomy precluding identification of acupuncture landmarks
  • Non-English speaking
  • Use of Hearing Aids that preclude the use of ear acupuncture
  • Allergy to Ibuprofen
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01302769


Locations
United States, Nevada
Mike O'Callaghan Federal Hosptial
Nellis AFB, Nevada, United States, 89191
Sponsors and Collaborators
Mike O'Callaghan Federal Hospital
Investigators
Principal Investigator: David Moss, M.D. Mike O'Callaghan Federal Hospital/Nellis Air Force Base
  More Information

Responsible Party: Mike O'Callaghan Federal Hospital
ClinicalTrials.gov Identifier: NCT01302769     History of Changes
Other Study ID Numbers: FWH20110008H
First Submitted: February 18, 2011
First Posted: February 24, 2011
Last Update Posted: February 3, 2016
Last Verified: February 2016

Keywords provided by Mike O'Callaghan Federal Hospital:
Acute Sore Throat
Ear Acupuncture

Additional relevant MeSH terms:
Pharyngitis
Pharyngeal Diseases
Stomatognathic Diseases
Respiratory Tract Infections
Respiratory Tract Diseases
Otorhinolaryngologic Diseases


To Top